A specially designed questionnaire was used to explore the predominant trends of pre-end stage renal failure in Egypt. A random sample of 47 physicians dealing with such patients was chosen to fill the questionnaire during a recent scientific gathering. They were of different ages, qualifications, years of experience and health-care disciplines. Collected data were entered into a computer database and subjected to statistical analysis and correlation with relevant physicians backgrounds. The study shows that the Egyptian trends are generally conforming to respective international recommendations; major deviations being largely the result of economical shortcomings. There was no significant impact of physician-related factors on patient management trends.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
[Uremic pericarditis in a not-so-terminal chronic kidney disease].
Rev Med Suisse
November 2024
Service de médecine interne, Réseau de l'arc, Hôpital de Moutier, 2740 Moutier.
Article Synopsis
- - A 90-year-old patient with stage G4 chronic kidney disease developed pneumonia and congestive heart failure, but his condition worsened despite treatment with levofloxacin and furosemide.
- - A CT scan showed pericardial effusion, suggesting uremic pericarditis, which is often seen in end-stage renal disease due to the buildup of toxins.
- - Initiating daily hemodialysis led to major improvement, highlighting the importance of early diagnosis and treatment to prevent complications in patients with kidney issues.
Investigation of cardiorenal outcomes and incidence of genitourinary tract infection after combined SGLT2 inhibitor and ACEI/ARB use in patients with chronic kidney disease stages 3-5: A real-world retrospective cohort study in Taiwan.
Int J Med Sci
September 2024
Department of Life Sciences, National Central University, Taoyuan, Taiwan.
Sodium‒glucose cotransporter-2 (SGLT2) inhibitors offer glycaemic and cardiorenal benefits in the early stage of chronic kidney disease (CKD). However, the use of SGLT2 inhibitors may increase the risk of genitourinary tract infection (GUTI). Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) may also cause deterioration of kidney function.
View Article and Find Full Text PDFChange Over Time in Pre-End-Stage Renal Disease 24-Hour Urine Creatinine as Muscle Mass Surrogate and Post-End-Stage Renal Disease Mortality.
J Ren Nutr
November 2024
University of Tennessee Health Science Center, Memphis, Tennessee; Memphis VA Medical Center, Memphis, Tennessee. Electronic address:
Objective: Loss of muscle mass and sarcopenia are common in chronic kidney disease (CKD) and end-stage renal disease (ESRD), and sarcopenia can worsen insidiously in patients with advancing CKD. The temporal dynamics of sarcopenia in patients with progressive loss of kidney function, and its association with future outcomes, is unclear.
Methods: In a contemporary national cohort of incident ESRD US veterans, we selected 661 patients who had at least 2 24-hour urine creatinine (24hrUC) measurements, a surrogate of muscle mass, performed during the 3-year prelude period prior to ESRD transition.
The Effects of Pharmacist-Led Medication Therapy Management on Medication Adherence and Use of Non-Steroidal Anti-Inflammatory Drug in Patients with Pre-End Stage Renal Disease.
Patient Prefer Adherence
February 2024
Department of Pharmacy, National Taiwan University Hospital, Taipei, Taiwan.
Purpose: Patients with chronic kidney disease (CKD) are particularly vulnerable to the risks of polypharmacy, largely owing to various comorbid conditions. This vulnerability is further compounded by an escalated risk of renal function deterioration when exposed to nephrotoxic medications. As part of the national health insurance program in Taiwan, the pre-end-stage kidney disease patient care and education plan has included pharmaceutical care since October 2021.
View Article and Find Full Text PDFEffects of AST-120 on mortality in patients with chronic kidney disease modeled by artificial intelligence or traditional statistical analysis.
Sci Rep
January 2024
School of Medicine, National Yang-Ming University, Taipei, Taiwan.
Chronic kidney disease (CKD) imposes a substantial burden, and patient prognosis remains grim. The impact of AST-120 (AST-120) on the survival of CKD patients lacks a consensus. This study aims to investigate the effects of AST-120 usage on the survival of CKD patients and explore the utility of artificial intelligence models for decision-making.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!